Single-dose trastuzumab monotherapy achieved pathological complete response (pCR) in a patient with HER2-positive breast cancer: a case report

BACKGROUND: With advances in breast cancer treatment, the importance of de-escalation therapy to reduce harm during the treatment of elderly patients has attracted attention in recent years. Certain patient populations are expected to have a superior response to anti-HER2 drugs, particularly those w...

Descripción completa

Detalles Bibliográficos
Autores principales: Isogai, Ayaka, Kotani, Haruru, Sawaki, Masataka, Hattori, Masaya, Yoshimura, Akiyo, Kataoka, Ayumi, Nozawa, Kazuki, Ozaki, Yuri, Endo, Yuka, Nakakami, Akira, Komaki, Rie, Iwata, Hiroji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10284776/
https://www.ncbi.nlm.nih.gov/pubmed/37341815
http://dx.doi.org/10.1186/s40792-023-01661-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10284776/
https://www.ncbi.nlm.nih.gov/pubmed/37341815
http://dx.doi.org/10.1186/s40792-023-01661-4

Ejemplares similares